ClinicalTrials.Veeva

Menu

Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea

Nobelpharma Co., Ltd. logo

Nobelpharma Co., Ltd.

Status and phase

Completed
Phase 3

Conditions

Dysmenorrhea

Treatments

Drug: Norethisterone,Ethinylestradiol
Drug: Sugar pill

Study type

Interventional

Funder types

Industry

Identifiers

NCT00212342
IKH-01-4

Details and patient eligibility

About

The purpose of this study is to determine whether combination oral contraceptive pill of Norethindrone & Ethinyl estradiol is effective in the treatment of dysmenorrhea associated with endometriosis.

Enrollment

100 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • dysmenorrhea associated with endometriosis

Exclusion criteria

  • severe hepatopathy
  • pregnant woman

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 2 patient groups, including a placebo group

Norethisterone,Ethinylestradiol
Experimental group
Treatment:
Drug: Norethisterone,Ethinylestradiol
Sugar pill
Placebo Comparator group
Treatment:
Drug: Sugar pill

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems